Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: A series of 4 cases

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1542-1545

  Gelber, Allan C ^a,b   Nousari, Hossein C ^a   Wigley, Fredrick M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Dermatomyositis; Mycophenolate mofetil

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; DERMATOMYOSITIS; EXANTHEMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TREATMENT OUTCOME;

EID: 0034041008     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487-96.
2. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
3. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanton TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995;122:715-24.
4. Nousari HC, Sgragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. Mycopohenolate mofetil in autoimmune and inflammatory skin diseases. J Am Acad Dermatol 1999;40:265-8.
5. Radis CD, Kahl LE, Baker GL, et al. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:1120-7.
6. Matteson EL, Hickey AR, Maguire L, Tilson HH, Urowitz MB. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 1991;18:809-14.
7. Lipsky JJ. Mycophenolate mofetil. Lancet 1996;348:1357-9.
8. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med 1999;130:422-6.
9. Nousari HC, Ha VT, Laman SD, Provost TT, Tausk FA. Centripetal flagellate erythema: a cutaneous manifestation associated with dermatomyositis. J Rheumatol 1999;26:692-5.
10. Nousari HC, Lynch W, Anhalt GJ, Petri M. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol 1998;134:1509-11.
11. Nousari HC, Griffin WA, Anhalt GJ. Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol 1998;39:497-8.
12. Enk AH, Knop J. Treatment of relapsing idiopathic nodular panniculitis (Pfeifer-Weber-Christian disease) with mycophenolate mofetil. J Am Acad Dermatol 1998;39:508-9.
13. Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis 1998;32:318-22.
14. Briggs WA, Choi MJ, Scheel PJ. Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998;31:213-7.
15. Goldblum R. Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 1993;11 Suppl:117-9.